BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 27114197)

  • 1. Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases.
    Brock G; Ni X; Oelke M; Mulhall J; Rosenberg M; Seftel A; D'Souza D; Barry J
    J Sex Med; 2016 May; 13(5):860-75. PubMed ID: 27114197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily.
    Burns PR; Rosen RC; Dunn M; Baygani SK; Perelman MA
    J Sex Med; 2015 Mar; 12(3):720-7. PubMed ID: 25615445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
    Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
    J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
    Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
    Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration?
    Prasetyo DT; Raharja PAR; Mantiri BJ; Ringoringo DRL; Rahman IA; Felizio J; Tambunan MP; Fadhly SF; Rahardjo HE
    Acta Med Indones; 2019 Jul; 51(3):275-281. PubMed ID: 31699953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study.
    Buvat J; Hatzichristou D; Boess FG; Büttner H; Gehchan N; Henneges C; Porst H
    Int J Clin Pract; 2014 Sep; 68(9):1087-99. PubMed ID: 25123817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy.
    Moncada I; de Bethencourt FR; Lledó-García E; Romero-Otero J; Turbi C; Büttner H; Henneges C; Martinez Salamanca JI
    World J Urol; 2015 Jul; 33(7):1031-8. PubMed ID: 25155034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial.
    Brock G; Montorsi F; Costa P; Shah N; Martinez-Jabaloyas JM; Hammerer P; Ludovico GM; Lee JC; Henneges C; Hamidi K; Rossi A; Mulhall J; Büttner H
    Urology; 2015 May; 85(5):1090-1096. PubMed ID: 25813656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.
    Hatzichristou D; d'Anzeo G; Porst H; Buvat J; Henneges C; Rossi A; Hamidi K; Büttner H
    BMC Urol; 2015 Nov; 15():111. PubMed ID: 26563171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
    J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
    Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
    J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study.
    Hatzimouratidis K; Buvat J; Büttner H; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    Int J Impot Res; 2014; 26(6):223-9. PubMed ID: 24784894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.